8-K · ABBV

AbbVie files an 8-K on quarterly results

Filed with the SEC Oct 30, 2026, 7:51 AM ET · Posted Oct 30, 2026, 8:28 AM ET

AbbVie filed a Form 8-K on Oct 30, 2026 at 7:51 AM ET under Item 2.02 (Results of Operations and Financial Condition).

Under Item 2.02, the filing says: “On October 30, 2026, AbbVie Inc. issued a press release announcing financial results for the third quarter ended September 30, 2026.”

The filing attaches a press release as Exhibit 99.1.

Source

8-K filed Oct 30, 2026 (document)
Filing index on SEC EDGAR (all documents and exhibits)

Read the earnings recap: what the press release reported, with year-ago figures →

AbbVie company file → · More AbbVie filings

Disclosures

Editor holdings in ABBV: The editor holds no position in AbbVie (ABBV). As of Oct 25, 2026.
Last updated: Oct 30, 2026

A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold ABBV.